https://www.hsa.gov.sg/ctgtp/class2/summary-of-benefit-risk-assessment-reports/ The reports contain a summary of the quality, safety and efficacy of approved Class 2 CTGTPs, and HSA's benefit-risk assessment for the approvals. en Mon, 05 Oct 2026 16:30:22 +0800 Isomer (https://www.isomer.gov.sg) https://www.hsa.gov.sg/ctgtp/class2/summary-of-benefit-risk-assessment-reports/fucaso-suspension-for-infusionurn:isomer:resource:346074The summary report for this Class 2 CTGTP is available for downloadMon, 05 Oct 2026 00:00:00 +0800New drug application